AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 150 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 316 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 316 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 316 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 316 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 316 | -60.7% | 0.00% | – |
| Q3 2020 | $2,000 | -66.7% | 805 | +8.8% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 740 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | +20.0% | 740 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +66.7% | 740 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 740 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | -33.3% | 740 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 740 | +183.5% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 261 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 261 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | +50.0% | 261 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |